Why the study?
Continuous blood pressure monitoring using photoplethysmography faces challenges in real-world wearable scenarios, including poor signal quality, complex model computation, and the need for frequent calibration.
Does a personalized continuous BP tracking pipeline using single-channel PPG accurately monitor blood pressure in wearable scenarios?
Does a personalized continuous BP tracking pipeline using single-channel PPG accurately monitor blood pressure in wearable scenarios?
A novel personalized continuous blood pressure tracking pipeline using single-channel PPG demonstrated accuracy within AAMI standards, showing promise for deployment on wearable healthcare devices.
Answers are grounded in this paper and cite their sources.
Enables feasible personalized BP tracking via wearable PPG; leaves open clinical validation before practice adoption.
The real-time tracking of human physiopathology states can significantly enhance the quality of personalized healthcare services. Photoplethysmography (PPG) detection is a rapid, portable and non-invasive method for measuring blood flow volume, widely used for monitoring blood pressure (BP) and cardiovascular status. However, continuous BP monitoring technologies based on PPG face numerous challenges in real-world wearable scenarios, such as poor signal quality, complex model computation, and the need for frequent calibration. This work proposed a personalized continuous BP tracking pipeline that performed automatic PPG signal quality grading to reduce the difficulty of model fitting, introduced a lightweight BP model (SCI-GTCN) to alleviate computational complexity, and employed an adaptive calibration strategy to achieve long-term BP monitoring performance under different scenarios. The proposed pipeline was validated using data from 134 subjects in various monitoring scenarios (daytime, nighttime, and abnormal states), assessing the model's performance during rapid BP changes, circadian rhythm fluctuations, and long-term monitoring. The ME±SD was 0.99±7.91/0.36±5.43 mmHg. Overall, the results of our method are within the accuracy requirements of the Association for the Advancement of Medical Instrumentation (AAMI) standards, though the subject distribution differs. The method demonstrated good robustness and applicability, making it convenient for deployment on wearable devices and promising in the healthcare field.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: